Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Veterinary Therapeutics Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Anti-inflammatory
  • 1.3.3 Parasiticides
  • 1.3.4 Other
• 1.4 Market Segment by Application
  • 1.4.1 Global Veterinary Therapeutics Market Share by Application (2019-2025)
  • 1.4.2 Hospitals
  • 1.4.3 Veterinary Clinics
  • 1.4.4 Drug Stores
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Veterinary Therapeutics Market Size
  • 2.1.1 Global Veterinary Therapeutics Revenue 2014-2025
  • 2.1.2 Global Veterinary Therapeutics Sales 2014-2025
• 2.2 Veterinary Therapeutics Growth Rate by Regions
  • 2.2.1 Global Veterinary Therapeutics Sales by Regions 2014-2019
  • 2.2.2 Global Veterinary Therapeutics Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Veterinary Therapeutics Sales by Manufacturers
  • 3.1.1 Veterinary Therapeutics Sales by Manufacturers 2014-2019
  • 3.1.2 Veterinary Therapeutics Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Veterinary Therapeutics Revenue by Manufacturers (2014-2019)
  • 3.2.2 Veterinary Therapeutics Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Veterinary Therapeutics Market Concentration Ratio (CR5 and HHI)
• 3.3 Veterinary Therapeutics Price by Manufacturers
• 3.4 Key Manufacturers Veterinary Therapeutics Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Veterinary Therapeutics Market
• 3.6 Key Manufacturers Veterinary Therapeutics Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Anti-inflammatory Sales and Revenue (2014-2019)
  • 4.1.2 Parasiticides Sales and Revenue (2014-2019)
  • 4.1.3 Other Sales and Revenue (2014-2019)
• 4.2 Global Veterinary Therapeutics Sales Market Share by Type
• 4.3 Global Veterinary Therapeutics Revenue Market Share by Type
• 4.4 Veterinary Therapeutics Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Veterinary Therapeutics Sales by Application

6 United States

• 6.1 United States Veterinary Therapeutics Breakdown Data by Company
• 6.2 United States Veterinary Therapeutics Breakdown Data by Type
• 6.3 United States Veterinary Therapeutics Breakdown Data by Application

7 European Union

• 7.1 European Union Veterinary Therapeutics Breakdown Data by Company
• 7.2 European Union Veterinary Therapeutics Breakdown Data by Type
• 7.3 European Union Veterinary Therapeutics Breakdown Data by Application

8 China

• 8.1 China Veterinary Therapeutics Breakdown Data by Company
• 8.2 China Veterinary Therapeutics Breakdown Data by Type
• 8.3 China Veterinary Therapeutics Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Veterinary Therapeutics Breakdown Data by Company
• 9.2 Rest of World Veterinary Therapeutics Breakdown Data by Type
• 9.3 Rest of World Veterinary Therapeutics Breakdown Data by Application
• 9.4 Rest of World Veterinary Therapeutics Breakdown Data by Countries
  • 9.4.1 Rest of World Veterinary Therapeutics Sales by Countries
  • 9.4.2 Rest of World Veterinary Therapeutics Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Bayer AG
  • 10.1.1 Bayer AG Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Veterinary Therapeutics
  • 10.1.4 Veterinary Therapeutics Product Introduction
  • 10.1.5 Bayer AG Recent Development
• 10.2 Boehringer Ingelheim GmbH
  • 10.2.1 Boehringer Ingelheim GmbH Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Veterinary Therapeutics
  • 10.2.4 Veterinary Therapeutics Product Introduction
  • 10.2.5 Boehringer Ingelheim GmbH Recent Development
• 10.3 Ceva Sante Animale
  • 10.3.1 Ceva Sante Animale Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Veterinary Therapeutics
  • 10.3.4 Veterinary Therapeutics Product Introduction
  • 10.3.5 Ceva Sante Animale Recent Development
• 10.4 Dechra Pharmaceuticals PLC
  • 10.4.1 Dechra Pharmaceuticals PLC Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Veterinary Therapeutics
  • 10.4.4 Veterinary Therapeutics Product Introduction
  • 10.4.5 Dechra Pharmaceuticals PLC Recent Development
• 10.5 Eli Lilly and Company (Elanco Animal Health)
  • 10.5.1 Eli Lilly and Company (Elanco Animal Health) Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Veterinary Therapeutics
  • 10.5.4 Veterinary Therapeutics Product Introduction
  • 10.5.5 Eli Lilly and Company (Elanco Animal Health) Recent Development
• 10.6 Merck Animal Health
  • 10.6.1 Merck Animal Health Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Veterinary Therapeutics
  • 10.6.4 Veterinary Therapeutics Product Introduction
  • 10.6.5 Merck Animal Health Recent Development
• 10.7 Sanofi (Merial Animal Health)
  • 10.7.1 Sanofi (Merial Animal Health) Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Veterinary Therapeutics
  • 10.7.4 Veterinary Therapeutics Product Introduction
  • 10.7.5 Sanofi (Merial Animal Health) Recent Development
• 10.8 Virbac
  • 10.8.1 Virbac Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Veterinary Therapeutics
  • 10.8.4 Veterinary Therapeutics Product Introduction
  • 10.8.5 Virbac Recent Development
• 10.9 Vetoquinol S.A.
  • 10.9.1 Vetoquinol S.A. Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Veterinary Therapeutics
  • 10.9.4 Veterinary Therapeutics Product Introduction
  • 10.9.5 Vetoquinol S.A. Recent Development
• 10.10 Zoetis, Inc.
  • 10.10.1 Zoetis, Inc. Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Veterinary Therapeutics
  • 10.10.4 Veterinary Therapeutics Product Introduction
  • 10.10.5 Zoetis, Inc. Recent Development

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Veterinary Therapeutics Sales Channels
  • 11.2.2 Veterinary Therapeutics Distributors
• 11.3 Veterinary Therapeutics Customers

12 Market Forecast

• 12.1 Global Veterinary Therapeutics Sales and Revenue Forecast 2019-2025
• 12.2 Global Veterinary Therapeutics Sales Forecast by Type
• 12.3 Global Veterinary Therapeutics Sales Forecast by Application
• 12.4 Veterinary Therapeutics Forecast by Regions
  • 12.4.1 Global Veterinary Therapeutics Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Veterinary Therapeutics Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

In 2019, the market size of Veterinary Therapeutics is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Veterinary Therapeutics.

This report studies the global market size of Veterinary Therapeutics, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Veterinary Therapeutics sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Bayer AG
Boehringer Ingelheim GmbH
Ceva Sante Animale
Dechra Pharmaceuticals PLC
Eli Lilly and Company (Elanco Animal Health)
Merck Animal Health
Sanofi (Merial Animal Health)
Virbac
Vetoquinol S.A.
Zoetis, Inc.

Market Segment by Product Type
Anti-inflammatory
Parasiticides
Other

Market Segment by Application
Hospitals
Veterinary Clinics
Drug Stores

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Veterinary Therapeutics status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Veterinary Therapeutics manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Veterinary Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025